Table 2.
Associations between TNKS and clinical features of ovarian cancer.
| Features | TNKS | |||||
|---|---|---|---|---|---|---|
| N | Low | High | X 2 | P | ||
| Age | <60 | 51 | 30 | 21 | 0.0919 | 0.7618 |
| ≥60 | 24 | 15 | 9 | |||
|
| ||||||
| Pathological differentiation | I, II | 40 | 27 | 13 | 6.3311 | 0.0119 |
| II-III, III | 23 | 8 | 15 | |||
|
| ||||||
| Pathological tissue | Clear cell adenocarcinoma | 6 | 6 | 0 | 13.94 | 0.0160 |
| Endometrioid adenocarcinoma | 6 | 4 | 2 | |||
| Mucinous adenocarcinoma | 9 | 4 | 5 | |||
| Serous adenocarcinoma | 40 | 22 | 18 | |||
| Stromal cell cancer | 3 | 0 | 3 | |||
| Germinoma | 6 | 6 | 0 | |||
|
| ||||||
| Tumor diameter | d≤10 | 30 | 25 | 5 | 15.26 | 0.0005 |
| 10<d<15 | 18 | 6 | 12 | |||
| d≥15 | 14 | 5 | 9 | |||